Fri, Jul 11, 2014, 6:32 AM EDT - U.S. Markets open in 2 hrs 58 mins

Recent

% | $
Quotes you view appear here for quick access.

EntreMed, Inc. Message Board

  • unpredictable_trader unpredictable_trader Oct 28, 2007 10:31 AM Flag

    Royalty on Thalomid and Revlimid?

    Can someone clarify what the royalty terms are? See SmartMoney article titled "Celgene's Fast Growth Hinges on Cancer Drug". Article is dated October 17?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Would it be possible for someone from ENMD interpet these most recent and wellcomed news releases. How will these results help the co and how long will it take before the co can expect to sell something? What will the co with these positive results? Are the results strong enough for the FDA to notice? Help?

      • 1 Reply to r10211940
      • I'm not from the company, but before there can be an approval, there would have to be a New Drug Application (NDA)(which the FDA would take at least several months to ponder since it's delivery would consume something the size of a minivan). Before there was an NDA, there would be a study (presumably published) showing significant substantiated, and probably repeated, efficacy. We should be prepared for all this to take at least a year and possibly two.

        However, before getting gloomy, remember that at each step the uncertainties should decrease and the liklihood of success should increase. This will increase the value of the company (look at ISIS over the past year as an example).

        ENMD is looked at by Wall Street today in the same category as a large number of small Biotechs with zero revenues and more distant, much more narrow drugs, IMO. The stock should be expected to appreciate as the company becomes more appreciated.

 
ENMD
1.740.00(0.00%)Jun 13 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.